Pfizer’s Coronavirus vaccine protects against the Delta variant, but is its effectiveness 41% or 88%?
Category: technology
Johnson & Johnson Executives Say Administration Of The Company’s Covid-19 Vaccine Will Resume Soon
Regulators in the EU and US meet this week to determine whether to resume administering the vaccine after reports of an extremely rare blood clotting side effect.
Are Humans More Sensitive To Screams From Sex Than From Fear?
A study claims that the brain processes alarm calls less efficiently than a scream of pleasure or joy.
How The Johnson & Johnson Vaccine Pause Might Slow Down The Global Covid-19 Response
Richer countries have the luxury of picking and choosing between vaccine options, but their regulatory decisions may make it harder for poorer countries to fight the pandemic.
General Catalyst Doubles Down On Healthcare With $600 Million New Fund
The venture capital firm’s first vertical-specific fund will invest in early- and growth-stage health startups, with hospital systems along for the ride.
To Understand Variants, You Must Stop Saying ‘The’ Coronavirus
Thinking of SARS-CoV-2 as a single virus stops you from understanding variants.
Coronavirus Variants Are Evolving – Even Inside A Single Person
The emergence of Coronavirus variants is a clear example of evolution in action.
What Is Life? A Biologist Explains Why There’s Still No Definition
Scientists and philosophers have failed to find a universal definition of life. Do we really need one?
At Least A Third Of Coronavirus Infections Are Asymptomatic
A systematic review has revealed the proportion of people who never develop symptoms of Covid.
Federal Grand Jury Indicts uBiome Cofounders On Criminal Fraud Charges
On Thursday, a Federal grand jury indicted biotech startup uBiome’s cofounders Jessica Richman and Michael Apte with multiple charges related to defrauding insurance companies and investors.
